Fig. 1From: Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritisDisposition of patients. FAS, full analysis; PPS, per-protocol main analysis set; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive protein. *Not meeting inclusion criteria for remission (BASDAI ≤ 2 and CRP ≤ upper limit of normality)Back to article page